Explore more publications!

France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

Press releases published on September 10, 2025

Adventour Paris Expands Into Italy, Spain, and Croatia to Redefine Luxury Travel
YAAZ evokes the atmosphere of the desert with the FESS Gazebo
Entrepreneur Kerry W. Kirby Delivers on Philanthropic Mission to Expand Access to Lifesaving Dialysis Care in Louisiana
Silver Market Growth Expected at 3.24% CAGR to Reach USD 30 Billion by 2035
Consumer Identity And Access Management Market Size to Reach USD 38.71 Billion by 2034, Growing at 10.16% CAGR
IXT Selects Valid to Deliver Global SIM Supply and OTA Platform
Avec un site web repensé, IRS - Integral Resources, veut rapprocher la technologie des entreprises et institutions
Furuno participating in Jammertest 2025, the world's largest GNSS resilience testing event
Neurones: 6.3% net profit in 1st half 2025
NEURONES : 6,3% de résultat net au 1er semestre 2025
Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs
Newlode devient Squad Cybersolutions pour renforcer la cohérence de marque au sein du Groupe Squad
Astek Accelerates in Spain and Strengthens Its European Footprint in the Aerospace Sector with the Acquisition of Quantion
Astek accélère en Espagne et s’impose en Europe dans le secteur de l’aérien grâce à Quantion
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
Communiqué de presse : Tzield approuvé en Chine comme premier traitement modificateur de la maladie pour les patients adultes et pédiatriques atteints de diabète de type 1 au stade 2

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions